POLK DENNIS

SEC source: 0001127602-21-002463 · form4a.xml · nonDerivative · entry 3

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,810

F3 · kind: Represents shares of restricted stock awarded under the 2020 Stock Incentive Plan. The restricted stock vests on the second anniversary of the date of grant.

SEC source: 0001127602-21-002463 · form4a.xml · nonDerivative · entry 2

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,145

F2 · kind: Represents shares of restricted stock awarded under the 2020 Stock Incentive Plan. The restricted stock vests as to one-third (1/3) of the shares on the first anniversary of the date of grant and two-thirds (2/3) of the shares on the second anniversary of the date of grant.

SEC source: 0001127602-21-002463 · form4a.xml · nonDerivative · entry 1

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,527

F1 · kind: Represents shares of restricted stock awarded under the 2020 Stock Incentive Plan. The restricted stock vests as to 20% of the shares on each of the first five anniversaries of October 7, 2020.

SEC source: 0001803599-20-000051 · wf-form4_160703912154098.xml · derivative · entry 9

POLK DENNIS · CIK 0001270710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,588

Underlying: Common Stock · 46,588 shares

Expires 2029-10-02

F2 · derivative.exercise_price: In connection with the spin-off of Concentrix by SYNNEX and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option cannot yet be determined and will be adjusted in accordance with the terms of the employee matters agreement. The exercise price set forth on this Form 4 reflects the exercise price of the original SYNNEX stock option and will be updated by amendment of this Form 4 once the adjusted exercise price is known.

F2 · kind: In connection with the spin-off of Concentrix by SYNNEX and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option cannot yet be determined and will be adjusted in accordance with the terms of the employee matters agreement. The exercise price set forth on this Form 4 reflects the exercise price of the original SYNNEX stock option and will be updated by amendment of this Form 4 once the adjusted exercise price is known.

F7 · derivative.exercise_date: The converted Concentrix stock option has the same vesting schedule as the original SYNNEX stock option, which vested as to 20% of the shares on October 2, 2020, the first anniversary of the date of grant, and vests as to 1/60th of the shares monthly thereafter.

SEC source: 0001803599-20-000051 · wf-form4_160703912154098.xml · derivative · entry 8

POLK DENNIS · CIK 0001270710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,003

Underlying: Common Stock · 71,003 shares

Expires 2028-10-11

F2 · derivative.exercise_price: In connection with the spin-off of Concentrix by SYNNEX and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option cannot yet be determined and will be adjusted in accordance with the terms of the employee matters agreement. The exercise price set forth on this Form 4 reflects the exercise price of the original SYNNEX stock option and will be updated by amendment of this Form 4 once the adjusted exercise price is known.

F2 · kind: In connection with the spin-off of Concentrix by SYNNEX and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option cannot yet be determined and will be adjusted in accordance with the terms of the employee matters agreement. The exercise price set forth on this Form 4 reflects the exercise price of the original SYNNEX stock option and will be updated by amendment of this Form 4 once the adjusted exercise price is known.

F6 · derivative.exercise_date: The converted Concentrix stock option has the same vesting schedule as the original SYNNEX stock option, which vested as to 20% of the shares on October 11, 2019, the first anniversary of the date of grant, and vests as to 1/60th of the shares monthly thereafter.

SEC source: 0001803599-20-000051 · wf-form4_160703912154098.xml · derivative · entry 7

POLK DENNIS · CIK 0001270710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,851

Underlying: Common Stock · 37,851 shares

Expires 2028-04-09

F2 · derivative.exercise_price: In connection with the spin-off of Concentrix by SYNNEX and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option cannot yet be determined and will be adjusted in accordance with the terms of the employee matters agreement. The exercise price set forth on this Form 4 reflects the exercise price of the original SYNNEX stock option and will be updated by amendment of this Form 4 once the adjusted exercise price is known.

F2 · kind: In connection with the spin-off of Concentrix by SYNNEX and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option cannot yet be determined and will be adjusted in accordance with the terms of the employee matters agreement. The exercise price set forth on this Form 4 reflects the exercise price of the original SYNNEX stock option and will be updated by amendment of this Form 4 once the adjusted exercise price is known.

F5 · derivative.exercise_date: The converted Concentrix stock option has the same vesting schedule as the original SYNNEX stock option, which vested as to 20% of the shares on October 3, 2018 and vests as to 1/60th of the shares monthly thereafter.

SEC source: 0001803599-20-000051 · wf-form4_160703912154098.xml · derivative · entry 6

POLK DENNIS · CIK 0001270710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,188

Underlying: Common Stock · 12,188 shares

Expires 2027-10-03

F2 · derivative.exercise_price: In connection with the spin-off of Concentrix by SYNNEX and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option cannot yet be determined and will be adjusted in accordance with the terms of the employee matters agreement. The exercise price set forth on this Form 4 reflects the exercise price of the original SYNNEX stock option and will be updated by amendment of this Form 4 once the adjusted exercise price is known.

F2 · kind: In connection with the spin-off of Concentrix by SYNNEX and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option cannot yet be determined and will be adjusted in accordance with the terms of the employee matters agreement. The exercise price set forth on this Form 4 reflects the exercise price of the original SYNNEX stock option and will be updated by amendment of this Form 4 once the adjusted exercise price is known.

F4 · derivative.exercise_date: The converted Concentrix stock option has the same vesting schedule as the original SYNNEX stock option, which vested as to 20% of the shares on October 3, 2018, the first anniversary of the date of grant, and vests as to 1/60th of the shares monthly thereafter.

SEC source: 0001803599-20-000051 · wf-form4_160703912154098.xml · derivative · entry 5

POLK DENNIS · CIK 0001270710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,778

Underlying: Common Stock · 13,778 shares

Expires 2026-10-04

F2 · derivative.exercise_price: In connection with the spin-off of Concentrix by SYNNEX and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option cannot yet be determined and will be adjusted in accordance with the terms of the employee matters agreement. The exercise price set forth on this Form 4 reflects the exercise price of the original SYNNEX stock option and will be updated by amendment of this Form 4 once the adjusted exercise price is known.

F2 · kind: In connection with the spin-off of Concentrix by SYNNEX and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option cannot yet be determined and will be adjusted in accordance with the terms of the employee matters agreement. The exercise price set forth on this Form 4 reflects the exercise price of the original SYNNEX stock option and will be updated by amendment of this Form 4 once the adjusted exercise price is known.

F3 · derivative.exercise_date: The converted Concentrix stock option has the same vesting schedule as the original SYNNEX stock option, which vested as to 20% of the shares on October 4, 2017, the first anniversary of the date of grant, and vests as to 1/60th of the shares monthly thereafter.

SEC source: 0001803599-20-000051 · wf-form4_160703912154098.xml · derivative · entry 4

POLK DENNIS · CIK 0001270710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,235

Underlying: Common Stock · 11,235 shares

Expires 2025-10-06

F2 · derivative.exercise_price: In connection with the spin-off of Concentrix by SYNNEX and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option cannot yet be determined and will be adjusted in accordance with the terms of the employee matters agreement. The exercise price set forth on this Form 4 reflects the exercise price of the original SYNNEX stock option and will be updated by amendment of this Form 4 once the adjusted exercise price is known.

F2 · kind: In connection with the spin-off of Concentrix by SYNNEX and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option cannot yet be determined and will be adjusted in accordance with the terms of the employee matters agreement. The exercise price set forth on this Form 4 reflects the exercise price of the original SYNNEX stock option and will be updated by amendment of this Form 4 once the adjusted exercise price is known.

SEC source: 0001803599-20-000051 · wf-form4_160703912154098.xml · derivative · entry 3

POLK DENNIS · CIK 0001270710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,514

Underlying: Common Stock · 15,514 shares

Expires 2024-10-07

F2 · derivative.exercise_price: In connection with the spin-off of Concentrix by SYNNEX and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option cannot yet be determined and will be adjusted in accordance with the terms of the employee matters agreement. The exercise price set forth on this Form 4 reflects the exercise price of the original SYNNEX stock option and will be updated by amendment of this Form 4 once the adjusted exercise price is known.

F2 · kind: In connection with the spin-off of Concentrix by SYNNEX and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option cannot yet be determined and will be adjusted in accordance with the terms of the employee matters agreement. The exercise price set forth on this Form 4 reflects the exercise price of the original SYNNEX stock option and will be updated by amendment of this Form 4 once the adjusted exercise price is known.

SEC source: 0001803599-20-000051 · wf-form4_160703912154098.xml · derivative · entry 2

POLK DENNIS · CIK 0001270710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,584

Underlying: Common Stock · 10,584 shares

Expires 2023-10-03

F2 · derivative.exercise_price: In connection with the spin-off of Concentrix by SYNNEX and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option cannot yet be determined and will be adjusted in accordance with the terms of the employee matters agreement. The exercise price set forth on this Form 4 reflects the exercise price of the original SYNNEX stock option and will be updated by amendment of this Form 4 once the adjusted exercise price is known.

F2 · kind: In connection with the spin-off of Concentrix by SYNNEX and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option cannot yet be determined and will be adjusted in accordance with the terms of the employee matters agreement. The exercise price set forth on this Form 4 reflects the exercise price of the original SYNNEX stock option and will be updated by amendment of this Form 4 once the adjusted exercise price is known.

SEC source: 0001803599-20-000051 · wf-form4_160703912154098.xml · nonDerivative · entry 1

POLK DENNIS · CIK 0001270710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,966

F1 · kind: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX"), on December 1, 2020, SYNNEX distributed all of the issued and outstanding shares of Concentrix common stock to SYNNEX stockholders (the "Distribution"). SYNNEX stockholders received one share of Concentrix common stock for each share of SYNNEX common stock held as of the close of business on November 17, 2020. The number of shares of Concentrix common stock reported as acquired on this Form 4 reflects the number of shares of Concentrix common stock, including shares of restricted stock, acquired by the reporting person pursuant to the Distribution.

SEC source: 0001803599-20-000060 · wf-form4a_160738772776148.xml · derivative · entry 8

POLK DENNIS · CIK 0001270710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,588

Underlying: Common Stock · 46,588 shares

Expires 2029-10-02

F1 · derivative.exercise_price: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX") and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option was determined on December 4, 2020 in accordance with the terms of the employee matters agreement. This Form 4/A is being filed to report the adjusted exercise price.

F1 · kind: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX") and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option was determined on December 4, 2020 in accordance with the terms of the employee matters agreement. This Form 4/A is being filed to report the adjusted exercise price.

F6 · derivative.exercise_date: The converted Concentrix stock option has the same vesting schedule as the original SYNNEX stock option, which vested as to 20% of the shares on October 2, 2020, the first anniversary of the date of grant, and vests as to 1/60th of the shares monthly thereafter.

SEC source: 0001803599-20-000060 · wf-form4a_160738772776148.xml · derivative · entry 7

POLK DENNIS · CIK 0001270710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,003

Underlying: Common Stock · 71,003 shares

Expires 2028-10-11

F1 · derivative.exercise_price: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX") and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option was determined on December 4, 2020 in accordance with the terms of the employee matters agreement. This Form 4/A is being filed to report the adjusted exercise price.

F1 · kind: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX") and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option was determined on December 4, 2020 in accordance with the terms of the employee matters agreement. This Form 4/A is being filed to report the adjusted exercise price.

F5 · derivative.exercise_date: The converted Concentrix stock option has the same vesting schedule as the original SYNNEX stock option, which vested as to 20% of the shares on October 11, 2019, the first anniversary of the date of grant, and vests as to 1/60th of the shares monthly thereafter.

SEC source: 0001803599-20-000060 · wf-form4a_160738772776148.xml · derivative · entry 6

POLK DENNIS · CIK 0001270710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,851

Underlying: Common Stock · 37,851 shares

Expires 2028-04-09

F1 · derivative.exercise_price: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX") and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option was determined on December 4, 2020 in accordance with the terms of the employee matters agreement. This Form 4/A is being filed to report the adjusted exercise price.

F1 · kind: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX") and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option was determined on December 4, 2020 in accordance with the terms of the employee matters agreement. This Form 4/A is being filed to report the adjusted exercise price.

F4 · derivative.exercise_date: The converted Concentrix stock option has the same vesting schedule as the original SYNNEX stock option, which vested as to 20% of the shares on October 3, 2018 and vests as to 1/60th of the shares monthly thereafter.

SEC source: 0001803599-20-000060 · wf-form4a_160738772776148.xml · derivative · entry 5

POLK DENNIS · CIK 0001270710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,188

Underlying: Common Stock · 12,188 shares

Expires 2027-10-03

F1 · derivative.exercise_price: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX") and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option was determined on December 4, 2020 in accordance with the terms of the employee matters agreement. This Form 4/A is being filed to report the adjusted exercise price.

F1 · kind: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX") and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option was determined on December 4, 2020 in accordance with the terms of the employee matters agreement. This Form 4/A is being filed to report the adjusted exercise price.

F3 · derivative.exercise_date: The converted Concentrix stock option has the same vesting schedule as the original SYNNEX stock option, which vested as to 20% of the shares on October 3, 2018, the first anniversary of the date of grant, and vests as to 1/60th of the shares monthly thereafter.

SEC source: 0001803599-20-000060 · wf-form4a_160738772776148.xml · derivative · entry 4

POLK DENNIS · CIK 0001270710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,778

Underlying: Common Stock · 13,778 shares

Expires 2026-10-04

F1 · derivative.exercise_price: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX") and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option was determined on December 4, 2020 in accordance with the terms of the employee matters agreement. This Form 4/A is being filed to report the adjusted exercise price.

F1 · kind: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX") and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option was determined on December 4, 2020 in accordance with the terms of the employee matters agreement. This Form 4/A is being filed to report the adjusted exercise price.

F2 · derivative.exercise_date: The converted Concentrix stock option has the same vesting schedule as the original SYNNEX stock option, which vested as to 20% of the shares on October 4, 2017, the first anniversary of the date of grant, and vests as to 1/60th of the shares monthly thereafter.

SEC source: 0001803599-20-000060 · wf-form4a_160738772776148.xml · derivative · entry 3

POLK DENNIS · CIK 0001270710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,235

Underlying: Common Stock · 11,235 shares

Expires 2025-10-06

F1 · derivative.exercise_price: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX") and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option was determined on December 4, 2020 in accordance with the terms of the employee matters agreement. This Form 4/A is being filed to report the adjusted exercise price.

F1 · kind: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX") and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option was determined on December 4, 2020 in accordance with the terms of the employee matters agreement. This Form 4/A is being filed to report the adjusted exercise price.

SEC source: 0001803599-20-000060 · wf-form4a_160738772776148.xml · derivative · entry 2

POLK DENNIS · CIK 0001270710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,514

Underlying: Common Stock · 15,514 shares

Expires 2024-10-07

F1 · derivative.exercise_price: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX") and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option was determined on December 4, 2020 in accordance with the terms of the employee matters agreement. This Form 4/A is being filed to report the adjusted exercise price.

F1 · kind: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX") and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option was determined on December 4, 2020 in accordance with the terms of the employee matters agreement. This Form 4/A is being filed to report the adjusted exercise price.

SEC source: 0001803599-20-000060 · wf-form4a_160738772776148.xml · derivative · entry 1

POLK DENNIS · CIK 0001270710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,584

Underlying: Common Stock · 10,584 shares

Expires 2023-10-03

F1 · derivative.exercise_price: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX") and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option was determined on December 4, 2020 in accordance with the terms of the employee matters agreement. This Form 4/A is being filed to report the adjusted exercise price.

F1 · kind: In connection with the spin-off of Concentrix Corporation ("Concentrix") by SYNNEX Corporation ("SYNNEX") and pursuant to the employee matters agreement between SYNNEX and Concentrix, on December 1, 2020, each outstanding option to purchase SYNNEX common stock was converted into a stock option to purchase SYNNEX common stock and a stock option to purchase Concentrix common stock, in each case with respect to the same number of shares as the original SYNNEX stock option. The exercise price of the converted Concentrix stock option was determined on December 4, 2020 in accordance with the terms of the employee matters agreement. This Form 4/A is being filed to report the adjusted exercise price.

SEC source: 0001127602-20-027421 · form4.xml · nonDerivative · entry 2

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,966

SEC source: 0001127602-20-027421 · form4.xml · nonDerivative · entry 1

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,866

F1 · kind: Represents shares issued upon vesting of restricted stock units awarded on October 20, 2017 subject to satisfaction of performance metrics measured over a three-year period ended August 31, 2020 and continued employment through October 20, 2020.

SEC source: 0001127602-20-026928 · form4.xml · nonDerivative · entry 1

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,477

SEC source: 0001127602-20-026678 · form4.xml · nonDerivative · entry 3

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,541

SEC source: 0001127602-20-026678 · form4.xml · nonDerivative · entry 2

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,834

SEC source: 0001127602-20-026678 · form4.xml · nonDerivative · entry 1

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,250

SEC source: 0001127602-20-026547 · form4.xml · nonDerivative · entry 1

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,091

SEC source: 0000899243-20-012330 · doc4.xml · nonDerivative · entry 1

POLK DENNIS · CIK 0001270710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,462

SEC source: 0001127602-20-003074 · form4.xml · nonDerivative · entry 2

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,224

SEC source: 0001127602-20-003074 · form4.xml · nonDerivative · entry 1

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,886

F1 · kind: Represents shares issued upon vesting of restricted stock units awarded on January 27, 2017 subject to satisfaction of performance metrics measured over a three-year period ending November 30, 2019.

SEC source: 0001127602-20-002451 · form4.xml · derivative · entry 6

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 158 shares

Expires 2022-10-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: This stock option is immediately exercisable and there are no longer any shares subject to this option.

SEC source: 0001127602-20-002451 · form4.xml · derivative · entry 5

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 139 shares

Expires 2021-10-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: This stock option is immediately exercisable and there are no longer any shares subject to this option.

SEC source: 0001127602-20-002451 · form4.xml · derivative · entry 4

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 623 shares

Expires 2020-10-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: This stock option is immediately exercisable and there are no longer any shares subject to this option.

SEC source: 0001127602-20-002451 · form4.xml · nonDerivative · entry 3

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,550

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-20-002451 · form4.xml · nonDerivative · entry 2

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,392

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-20-002451 · form4.xml · nonDerivative · entry 1

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,253

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-19-030482 · form4.xml · nonDerivative · entry 1

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,630

SEC source: 0001127602-19-030309 · form4.xml · nonDerivative · entry 2

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,695

SEC source: 0001127602-19-030309 · form4.xml · nonDerivative · entry 1

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,988

SEC source: 0001127602-19-030250 · form4.xml · nonDerivative · entry 1

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,403

SEC source: 0001127602-19-030200 · form4.xml · nonDerivative · entry 2

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,712

SEC source: 0001127602-19-030200 · form4.xml · nonDerivative · entry 1

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,932

SEC source: 0001127602-19-030173 · form4.xml · derivative · entry 2

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,588

Underlying: Common Stock · 46,588 shares

Expires 2029-10-02

F2 · derivative.exercise_date: This stock option vests as to 20% of the shares on the first anniversary of the date of grant and vests as to 1/60th of the shares monthly thereafter.

SEC source: 0001127602-19-030173 · form4.xml · nonDerivative · entry 1

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,225

F1 · kind: Represents shares of restricted stock awarded under the 2013 Stock Incentive Plan. The restricted stock vests as to 20% of the shares on each of the first five anniversaries of the date of grant.

SEC source: 0000899243-19-011773 · doc4.xml · nonDerivative · entry 1

POLK DENNIS · CIK 0001270710 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,597

SEC source: 0001127602-19-003926 · form4.xml · nonDerivative · entry 2

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,208

SEC source: 0001127602-19-003926 · form4.xml · nonDerivative · entry 1

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,862

F1 · kind: Represents shares issued upon vesting of restricted stock units awarded on January 12, 2016 subject to satisfaction of performance metrics measured over a three-year period ending November 30, 2018.

SEC source: 0001127602-18-030151 · form4.xml · derivative · entry 2

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,003

Underlying: Common Stock · 71,003 shares

Expires 2028-10-11

F2 · derivative.exercise_date: This stock option vests as to 20% of the shares on the first anniversary of the date of grant and vests as to 1/60th of the shares monthly thereafter.

SEC source: 0001127602-18-030151 · form4.xml · nonDerivative · entry 1

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,583

F1 · kind: Represents shares of restricted stock awarded under the 2013 Stock Incentive Plan. The restricted stock vests as to 20% of the shares on each of the first five anniversaries of the date of grant.

SEC source: 0001127602-18-029927 · form4.xml · nonDerivative · entry 2

POLK DENNIS · CIK 0001270710 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,387